2705, boulevard Laurier
R-00-750
Québec, Québec
Canada G1V 4G2
Dernières nouvelles
Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus Erythematosus
Article de revueArthritis Rheumatol, 74 (7), 2022.
A Novel Case of Complement Factor B Deficiency
Article de revueJ Clin Immunol, 41 (1), 2021.
Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations
Article de revueSci Rep, 9 (1), 2019.
Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency
Article de revueFront Immunol, 9 , 2018.
Allogeneic dendritic cells stimulated with antibodies against HLA class II polarize naive T cells in a follicular helper phenotype
Article de revueSci Rep, 8 (1), 2018.
Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study
Article de revueTranspl Int, 30 (5), 2017.
Donor-specific antibodies require preactivated immune system to harm renal transplant
Article de revueEBioMedicine, 9 , 2016.
2013 Banff Criteria for Chronic Active Antibody-Mediated Rejection: Assessment in a Real-Life Setting
Article de revueAm J Transplant, 16 (5), 2016.
The isolated human umbilical vein as a bioassay for kinin-generating proteases: An in vitro model for therapeutic angioedema agents
Article de revueLife Sci, 155 , 2016.
Clinical relevance of circulating antibodies and B lymphocyte markers in allograft rejection
Article de revueClin Biochem, 49 (4-5), 2016.
Projets terminés récemment
- Precision Medicine CanPREVENT AMR: Applying Precision Medicine Technologies in Canada to Prevent Antibody Mediated Rejection and Premature Kidney Transplant Loss, du 2018-04-01 au 2022-03-31